Interval and point estimation in adaptive Phase II trials with binary endpoint.

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Oncology Research

Background:

• Phase II clinical trials determine treatment efficacy for further Phase III investigation.
• Frequentist group-sequential designs are standard in oncology but lack flexibility.
• Adaptive designs offer enhanced flexibility for sample size adjustments.

Purpose of the Study:

• To propose novel point and interval estimation methods for adaptive Phase II oncology trial designs.
• To enhance decision-making regarding treatment progression based on early efficacy data.
• To improve the statistical performance of adaptive designs over existing methods.

Main Methods:

• Development of estimation methods based on sample space orderings.
• Derivation of p-values, point estimates, and interval estimates for adaptive designs.
• Simulation studies to evaluate the performance of the proposed methods.

Main Results:

• The proposed methods provide accurate point and interval estimates for adaptive designs.
• Adaptive designs allow for sample size adjustments based on early response data.
• Simulations demonstrate reduced bias and root mean square error compared to fixed-sample methods.

Conclusions:

• The proposed estimation methods enhance the statistical rigor of adaptive Phase II oncology trials.
• Adaptive designs offer a more flexible and efficient approach to evaluating cancer treatments.
• These advancements can lead to more informed decisions in clinical trial progression.